Human Metabolome Technologies, Inc.

TSE:6090 Stock Report

Market Cap: JP¥3.8b

Human Metabolome Technologies Management

Management criteria checks 1/4

Human Metabolome Technologies' CEO is Yasuhiro Ohata, appointed in Sep 2020, has a tenure of 4.42 years. directly owns 0.13% of the company’s shares, worth ¥4.84M. The average tenure of the management team and the board of directors is 3.3 years and 2.4 years respectively.

Key information

Yasuhiro Ohata

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.4yrs
CEO ownership0.1%
Management average tenure3.3yrs
Board average tenure2.4yrs

Recent management updates

Recent updates

Human Metabolome Technologies' (TSE:6090) Weak Earnings May Only Reveal A Part Of The Whole Picture

Oct 03
Human Metabolome Technologies' (TSE:6090) Weak Earnings May Only Reveal A Part Of The Whole Picture

Human Metabolome Technologies, Inc.'s (TSE:6090) Business And Shares Still Trailing The Market

Aug 06
Human Metabolome Technologies, Inc.'s (TSE:6090) Business And Shares Still Trailing The Market

Human Metabolome Technologies (TSE:6090) Is Increasing Its Dividend To ¥15.00

Jun 07
Human Metabolome Technologies (TSE:6090) Is Increasing Its Dividend To ¥15.00

Human Metabolome Technologies (TSE:6090) Is Increasing Its Dividend To ¥15.00

May 22
Human Metabolome Technologies (TSE:6090) Is Increasing Its Dividend To ¥15.00

Human Metabolome Technologies (TSE:6090) Is Paying Out A Larger Dividend Than Last Year

Apr 06
Human Metabolome Technologies (TSE:6090) Is Paying Out A Larger Dividend Than Last Year

Human Metabolome Technologies (TSE:6090) Is Increasing Its Dividend To ¥15.00

Mar 23
Human Metabolome Technologies (TSE:6090) Is Increasing Its Dividend To ¥15.00

Human Metabolome Technologies (TSE:6090) Will Pay A Larger Dividend Than Last Year At ¥15.00

Feb 26
Human Metabolome Technologies (TSE:6090) Will Pay A Larger Dividend Than Last Year At ¥15.00

CEO

Yasuhiro Ohata (59 yo)

4.4yrs

Tenure

Mr. Yasuhiro Ohata is President of Human Metabolome Technologies, Inc. from July 2024 and is its CFO since September 2020. Mr. Ohata was Director of Corporate Headquarters & Director of Human Metabolome Te...

Leadership Team

NamePositionTenureCompensationOwnership
Yasuhiro Ohata
President4.4yrsno data0.13%
¥ 4.8m
Masaru Tomita
Co-Founder and Member of Technical Advisory Board22.1yrsno data6.59%
¥ 249.6m
Tomoyoshi Soga
Co-Founder and Member of Technical Advisory Board22.1yrsno data3.51%
¥ 133.1m
Kenjiro Kami
COO, GM of Business Management Division & Director1.1yrsno datano data
Jun Nagashima
Chief Information Officer & Executive Officer1.1yrsno datano data
Atsushi Nagashima
Executive Officer & GM of Information System Departmentno datano datano data
Naotaka Kametani
Executive Officer & Chief Alliance Officer2.1yrsno datano data

3.3yrs

Average Tenure

51yo

Average Age

Experienced Management: 6090's management team is considered experienced (3.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Yasuhiro Ohata
President4.4yrsno data0.13%
¥ 4.8m
Masaru Tomita
Co-Founder and Member of Technical Advisory Boardno datano data6.59%
¥ 249.6m
Tomoyoshi Soga
Co-Founder and Member of Technical Advisory Boardno datano data3.51%
¥ 133.1m
Kenjiro Kami
COO, GM of Business Management Division & Directorless than a yearno datano data
Natsukari Hajime
Independent Director2.4yrsno datano data

2.4yrs

Average Tenure

49yo

Average Age

Experienced Board: 6090's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/01 08:11
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Human Metabolome Technologies, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kiyokazu YamazakiIchiyoshi Research Institute Inc.